2016 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
December 09, 2016
Voyager Therapeutics to Attend Upcoming Investor Conference
December 07, 2016
Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
November 29, 2016
Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors
November 10, 2016
Voyager Therapeutics Provides Third Quarter 2016 Investor Update
November 01, 2016
Voyager Therapeutics to Host Third Quarter 2016 Investor Update Call
October 18, 2016
Voyager Therapeutics Announces Planned Transition Process for Chief Financial Officer
September 15, 2016
Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology
September 12, 2016
Voyager Therapeutics and CHDI Foundation Collaborate to Develop Novel Gene Therapy for Huntington’s Disease
August 12, 2016
Voyager Therapeutics to Attend Upcoming Investor Conferences
August 11, 2016
Voyager Therapeutics Provides Second Quarter 2016 Investor Update
August 09, 2016
Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinson’s Disease
August 04, 2016
Voyager Therapeutics to Host Second Quarter 2016 Investor Update Call
June 22, 2016
Voyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinson’s Disease
May 12, 2016
Voyager Therapeutics Provides First Quarter 2016 Investor Update
May 11, 2016
Voyager Therapeutics to Present at Upcoming Investor Conferences
May 05, 2016
Voyager Therapeutics to Host First Quarter 2016 Investor Update Call
April 29, 2016
Voyager Therapeutics Highlights Programs in Parkinson’s Disease and ALS; Announces Expansion of CNS Pipeline at R&D Day
April 14, 2016
Voyager Therapeutics to Host R&D Day and Webcast on April 29, 2016
March 17, 2016
Voyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update
March 14, 2016
Voyager Therapeutics to Present at Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Therapy Investor Day
March 10, 2016
Voyager Therapeutics to Host Fourth Quarter and Full Year 2015 Investor Update Call
February 29, 2016
Voyager Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
February 02, 2016
Voyager Therapeutics Promotes Jeff Goater to Chief Financial Officer